Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
Clinical trial NCT00002669 · COMPLETED
Trial details
- NCT number
- NCT00002669
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1995-06-01
- Primary completion
- 2002-08-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.